title: A pilot trial of pentoxifylline on endothelial function and inflammation in HIV-infected patients initiating antiretroviral therapy.
authors.affiliation: aDivision of Infectious Diseases, Indiana University School of Medicine, Indianapolis, Indiana bDivision of Infectious Diseases, University of Southern California Keck School of Medicine, Los Angeles, California cDivision of Cardiovascular Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin dDepartment of Cellular & Integrative Physiology, Center for Vascular Biology eDepartment of Biostatistics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
authors.forename: Samir K
authors.initials: SK
authors.lastname: Gupta
authors.forename: Michael P
authors.initials: MP
authors.lastname: Dubé
authors.forename: James H
authors.initials: JH
authors.lastname: Stein
authors.forename: Matthias A
authors.initials: MA
authors.lastname: Clauss
authors.forename: Ziyue
authors.initials: Z
authors.lastname: Liu
mesh_terms: D000328:Adult; D023241:Antiretroviral Therapy, Highly Active; D015415:Biomarkers / Q000097:blood; D004730:Endothelium, Vascular / Q000187:drug effects*; D005260:Female; D015658:HIV Infections / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007249:Inflammation / Q000097:blood / Q000188:drug therapy; D008297:Male; D010431:Pentoxifylline / Q000008:administration & dosage / Q000627:therapeutic use*; D010865:Pilot Projects; D014657:Vasculitis / Q000097:blood / Q000188:drug therapy*; D014664:Vasodilation / Q000187:drug effects; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D015415:Biomarkers; D014665:Vasodilator Agents; D010431:Pentoxifylline